Immunogenicity of an Inactivated COVID-19 Vaccine

NCT05198336 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
395
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sinovac Research and Development Co., Ltd.